Skip to content

The therapeutic effect of high-dose moxibustion on the treatment of herpes zoster patients:A study protocol for a multicenter randomized controlled trial

Clinical study on the treatment of herpes zoster/post-neuralgia based on comprehensive moxibustion therapy based on ''Huo Yu Fa Zhi''

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006732
Enrollment
Unknown
Registered
2022-10-31
Start date
2022-10-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

Group C:drug
Group A:TCM External Treatment + high-dose moxibustion + drug
Group B:TCM External Treatment + drug

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria of traditional Chinese and Western medicine for herpes zoster; 2. Aged 18-70 years, no gender limit; 3. Visual analog scale (VAS) score >= 4 points before treatment, and no relevant treatment within one week before enrollment; 4. Herpes occurs on the body and limbs; 5. Those who voluntarily participated in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant patients; 2. Patients who are unable to express their own symptoms voluntarily, or have disorders of consciousness, coagulation disorders, and sensory disorders; 3. Allergic constitution or allergic to acupuncture; 4. Patients with serious primary diseases; 5. Progressive malignant tumor or other serious wasting disease, easy to be complicated by infection and bleeding; 6. Those with other diseases that cause pain; 7. Those who are participating in other clinical trials recently.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale;Prevalence of postherpetic neuralgia;

Secondary

MeasureTime frame
zoster brief pain inventory;36-Item Short-Form Health Survey;

Countries

China

Contacts

Public ContactWu Jie
wujiejiaoshou@163.com+86 18981885750

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026